Arndt Vogel· @ArndtVogel · X·· 2 days agoScore70
Body · original
W&W strategy for dostarlimab in localized deficient dMMR/MSI-H GC/GEJC: Results from the first interim analysis of the GERCOR-GONO DEWI phase II study
#ESMO26 #ESMOAmbassadors
👉 25pts enrolled, 33% of pts achieved cCR at 1yr
👉 1 pts with PD
🧐Study continues
@myESMO @ASCO
424 views · 6 likes · 7 reposts · 0 replies
Conference abstracts
2877ROmatched by Rapid oral 1: Gastrointestinal tumour, upper digestive
Watch-and-wait (W&W) strategy for dostarlimab in localized deficient dMMR/MSI-H gastroesophageal adenocarcinoma (GEA): Results from the first interim analysis of the GERCOR-GONO DEWI phase II study
https://esmocongress.esmo.orgSource: Arndt Vogel · x.com